Drug Trial Radar · NCT00089700
TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1
Last checked: Nov 20, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
80
Actual
Start
Mar 2004
Primary completion
Not stated
Sponsor
- Lead sponsor
- TanoxIndustry
- Sponsor type
- Industry
- First posted
- Aug 12, 2004
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 48-week study to compare TNX-355 plus OBT to placebo plus OBT in HIV subjects. You must have a stable viral load of at least 10,000 copies/ml, been treated with highly active antiretroviral therapy (HAART) for at least 6 months, be triple class experienced, and presently failing or have failed a HAART regimen. Subjects will receive infusions every week for 8 weeks, then every two weeks.
Conditions
- HIV Infections
Interventions
TNX-355Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
15 sites in 3 countries. Site status is shown where the registry gives one.
Body Positive
Phoenix, Arizona
Altamed Corporation
Los Angeles, California
Tower ID Medical Associates
Los Angeles, California
Dupont Circle Physicians Group
Washington D.C., District of Columbia
IDC Research Initiative
Altamonte Springs, Florida
Bach and Godofsky
Bradenton, Florida
University of Miami
Miami, Florida
Comprehensive Research Institute
Tampa, Florida
Brobson Lutz, MD, LLC
New Orleans, Louisiana
Chase-Brexton Health Services, Inc.
Baltimore, Maryland
Johns Hopkins University School of Medicine
Baltimore, Maryland
University of Cincinnati Medical Center
Cincinnati, Ohio
Tanox, Inc.
Houston, Texas
Sunnybrook Health Science Centre
Toronto, Ontario, Canada
Clinical Research Puerto Rico, Inc.
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.